Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes

Rice NewsIn The News

Oct 2

Written By Christian Schreib

Christian Schreib

Rice launches RBL LLC to rapidly create biotech startups focused on delivering breakthrough therapies to patients

Rice Professor, Omid Veiseh, Elected to the Controlled Release Society College of Fellows